Curcumin-based nanoformulations as an emerging therapeutic strategy for inflammatory lung diseases

Asif Ahmad Bhat; Riya Thapa; Ahsas Goyal; Vetriselvan Subramaniyan; Deepak Kumar; Saurabh Gupta; Sachin Kumar Singh; Kamal Dua; Gaurav Gupta

doi:10.4155/fmc-2023-0048

Curcumin-based nanoformulations as an emerging therapeutic strategy for inflammatory lung diseases

Asif Ahmad Bhat, Riya Thapa, Ahsas Goyal, Vetriselvan Subramaniyan, Deepak Kumar, Saurabh Gupta, Sachin Kumar Singh, Kamal Dua, Gaurav Gupta

Malaysia Jeffrey Cheah Sch of Med & HS

Research output: Contribution to journal › Editorial › Other › peer-review

49 Citations (Scopus)

Original language	English
Pages (from-to)	583-586
Number of pages	4
Journal	Future Medicinal Chemistry
Volume	15
Issue number	7
DOIs	https://doi.org/10.4155/fmc-2023-0048
Publication status	Published - Apr 2023

Access to Document

10.4155/fmc-2023-0048

Cite this

@article{23f990064ee74e959288a0c348f357ee,

title = "Curcumin-based nanoformulations as an emerging therapeutic strategy for inflammatory lung diseases",

author = "Bhat, {Asif Ahmad} and Riya Thapa and Ahsas Goyal and Vetriselvan Subramaniyan and Deepak Kumar and Saurabh Gupta and Singh, {Sachin Kumar} and Kamal Dua and Gaurav Gupta",

note = "Funding Information: The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.",

year = "2023",

month = apr,

doi = "10.4155/fmc-2023-0048",

language = "English",

volume = "15",

pages = "583--586",

journal = "Future Medicinal Chemistry",

issn = "1756-8919",

publisher = "Future Science Ltd.",

number = "7",

}

TY - JOUR

T1 - Curcumin-based nanoformulations as an emerging therapeutic strategy for inflammatory lung diseases

AU - Bhat, Asif Ahmad

AU - Thapa, Riya

AU - Goyal, Ahsas

AU - Subramaniyan, Vetriselvan

AU - Kumar, Deepak

AU - Gupta, Saurabh

AU - Singh, Sachin Kumar

AU - Dua, Kamal

AU - Gupta, Gaurav

N1 - Funding Information: The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

PY - 2023/4

Y1 - 2023/4

UR - http://www.scopus.com/inward/record.url?scp=85159189897&partnerID=8YFLogxK

U2 - 10.4155/fmc-2023-0048

DO - 10.4155/fmc-2023-0048

M3 - Editorial

C2 - 37140132

AN - SCOPUS:85159189897

SN - 1756-8919

VL - 15

SP - 583

EP - 586

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

IS - 7

ER -

Curcumin-based nanoformulations as an emerging therapeutic strategy for inflammatory lung diseases

Access to Document

Other files and links

Cite this